Amanta Healthcare (NSE:AMANTA) ROCE %: 11.38% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:AMANTA Amanta Healthcare Ltd NSE:AMANTA
26 GF Score
Price ₹175.59
! 4 Warning Signs
View Full Analysis

What is Amanta Healthcare ROCE %?

Amanta Healthcare NSE:AMANTA -2.00% 26 ROCE % is 11.38% as of Mar. 2026. GuruFocus rates NSE:AMANTA with a GF Score™ of 26/100. The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Amanta Healthcare's annualized ROCE % for the quarter that ended in Mar. 2026 was 11.38%.

Amanta Healthcare  (NSE:AMANTA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Amanta Healthcare ROCE % Related Terms

Amanta Healthcare ROCE % Historical Data

* Premium members only.

The historical data trend for Amanta Healthcare's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amanta Healthcare ROCE % Chart

Amanta Healthcare Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
39.17 13.61 14.33 16.50 12.25

Amanta Healthcare Quarterly Data
Mar22 Mar23 Mar24 Sep24 Dec24 Mar25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only 16.42 21.18 9.35 12.33 11.38
NSE:AMANTA
26GF Score
Amanta Healthcare Ltd NSE:AMANTA
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Amanta Healthcare ROCE % Calculation

Amanta Healthcare's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=418.704/( ( (3817.585 - 1150.826) + (5579.807 - 1410.568) )/ 2 )
=418.704/( (2666.759+4169.239)/ 2 )
=418.704/3417.999
=12.25 %

Amanta Healthcare's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=474.524/( ( (0 - 0) + (5579.807 - 1410.568) )/ 1 )
=474.524/( ( 0 + 4169.239 )/ 1 )
=474.524/4169.239
=11.38 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 11.38% mean?
Amanta Healthcare (NSE:AMANTA) has a ROCE % of 11.38% as of Mar. 2026.
Is Amanta Healthcare's ROCE % too high?
Amanta Healthcare's current ROCE % is 11.38%. The Drug Manufacturers industry median ROCE % is 7.04. Amanta Healthcare's value of 11.38% is 61.6% above this industry median. Overall, Amanta Healthcare has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Amanta Healthcare's ROCE % compare to ZTS and UTHR?
Amanta Healthcare's ROCE % of 11.38% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.04. Amanta Healthcare's value of 11.38% is 61.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.04, based on 964 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Amanta Healthcare's current ROCE % of 11.38% is 61.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amanta Healthcare's current ROCE % is 11.38%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amanta Healthcare stock overvalued right now?
Amanta Healthcare (NSE:AMANTA) has a current ROCE % of 11.38%. The current ROCE % is 11.38% and 61.6% above the Drug Manufacturers industry median of 7.04. Amanta Healthcare's overall GF Score™ is 26/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Amanta Healthcare (NSE:AMANTA), the current ROCE % is 11.38% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Amanta Healthcare Business Description

Other Exchanges 544502:India
Address C.J. Marg, 8th Floor, Shaligram Corporates, Ambli, Ahmedabad, GJ, IND, 380058
Amanta Healthcare Ltd is a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products - parenteral products, being packed in plastic container with Aseptic Blow-Fill-Seal and Injection Strech Blow Moulding technology. It manufactures large volume parenterals and small volume parenterals in six therapeutic segments. It also manufactures medical devices. The company manufactures fluid therapy, formulations, diluents, ophthalmic, respiratory care and irrigation solutions in therapeutic segment and products like irrigation, first-aid solution, eye lubricants etc. in medical device segment. It offers wide range of closure systems, such as nipple head, twist-off, leur-lock and screw types and container fill-volume till 1000 ml.
26GF Score

Get the complete analysis for NSE:AMANTA

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹175.59
Price